CVS offers lower-cost fertility medications
By Jessica Wohl
CHICAGO (Reuters) - CVS Caremark Corp said on Monday it is offering discounts of about 30 percent on fertility treatments to couples struggling with infertility and high medication costs.
The program is aimed at patients who do not have fertility medication health insurance coverage or who have exhausted their benefits for fertility medications.
CVS said about 7.3 million U.S. women and their partners, or about 12 percent of the reproductive-age population, are affected by infertility, citing data from the Centers for Disease Control and Prevention.
“On average patients will receive about 30 percent off for the cost of their medication,” said Joan O’Rourke, vice president of strategic operations at CVS Caremark Specialty Pharmacy.
Patients must pay a $10 fee to enroll in the program, which includes services such as counseling and education.
While the program was launched in February, CVS is promoting it at the American Society of Reproductive Medicine’s annual meeting this week.
Under a separate plan launched on Sunday, shoppers can get 90-day prescriptions for more than 400 common generic medications for $9.99 each at CVS drugstores when they pay an annual fee of $10.
About 45.7 million Americans were uninsured in 2007, according to the U.S. Census Bureau.
(Reporting by Jessica Wohl; Editing by Tim Dobbyn)
--------------------------------------------------------------------------------------------Related Posts:
CHICAGO (Reuters) - Walgreen Co said on Wednesday that it is marketing a combination of its clinics, pharmacies and other services to businesses looking to save on employee healthcare costs. Walgreen, best known for the thousands of drugstores it has across the United States, also runs hundreds of health clinics in stores and at corporate offices. The
Full Post: Walgreen offers health program for businesses
--------------------------------------------------------------------------------------------
By Karla Gale NEW YORK (Reuters Health) - The Society for Assisted Reproductive Technology (SART) has developed a comprehensive document for doctors to use when obtaining informed consent from patients seeking infertility treatment. “This is our compilation of the important elements of informed consent that should be reviewed with patients,” incoming SART president Dr. Elizabeth Ginsburg said
Full Post: Consent form developed for infertility therapy
--------------------------------------------------------------------------------------------
By Karla Gale NEW YORK (Reuters Health) - Freezing embryos before undergoing cancer treatment that may cause infertility is as successful for women with cancer as it is for women without cancer, new study findings indicate. The investigators, who presented their findings this week at the 64th annual meeting of the American Society of Reproductive Medicine in
Full Post: Embryo preservation often works for cancer patients
--------------------------------------------------------------------------------------------
NEW YORK (Reuters Health) - Depression, anxiety and certain other mental health conditions are more common among infertile couples than those who are able to conceive on their own, a small study suggests. The findings, say researchers, imply that routine mental health screening could benefit patients being treated for infertility. While most of the 81 infertile couples
Full Post: Mental woes more common in infertile couples
--------------------------------------------------------------------------------------------
By Joene Hendry NEW YORK (Reuters Health) - Canadian high school students may lack important knowledge about risk factors for infertility, survey findings suggest. For example, most students were unaware that some sexually transmitted infections can cause infertility. “About 80 percent of students said they were familiar with the term infertility,” Susan Quach, of Sunnybrook and Women’s
Full Post: Teens may not know risk factors for infertility